on Wellgistics Health, Inc. (NASDAQ:WGRX)
Wellgistics Health Achieves 36% Revenue Growth in Q1 2025
Wellgistics Health, Inc., a healthcare infrastructure and pharmaceutical distribution company, reported significant financial growth for Q1 2025, with revenue reaching $10.86 million. This marks a substantial increase from zero in the previous year. Adjusting for acquisitions made on January 1, 2024, the company saw a 36% revenue growth on a non-GAAP basis.
CEO Brian Norton attributes this growth to expanded manufacturer partnerships and a larger product portfolio. The company registered 354 new pharmacies, of which almost two-thirds have already placed orders. Wellgistics Health continues to enhance its technology infrastructure, including plans for its Peek platform expansion.
With these developments, the company anticipates further momentum in Q2, bolstered by increased clinical fulfillment capacity and new manufacturer integrations. The focus remains on strategic acceleration to fuel growth and market share expansion.
R. P.
Copyright © 2025 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Wellgistics Health, Inc. news